188 related articles for article (PubMed ID: 1462982)
1. Captopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy.
Elving LD; Wetzels JF; de Nobel E; Hoitsma AJ; Berden JH
Am J Kidney Dis; 1992 Dec; 20(6):559-63. PubMed ID: 1462982
[TBL] [Abstract][Full Text] [Related]
2. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
Parving HH; Hommel E; Jensen BR; Hansen HP
Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
[TBL] [Abstract][Full Text] [Related]
3. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
4. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
Parving HH; Hommel E; Smidt UM
BMJ; 1988 Oct; 297(6656):1086-91. PubMed ID: 3143437
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
Mathiesen ER; Hommel E; Giese J; Parving HH
BMJ; 1991 Jul; 303(6794):81-7. PubMed ID: 1860008
[TBL] [Abstract][Full Text] [Related]
6. Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
Elving LD; Wetzels JF; van Lier HJ; de Nobel E; Berden JH
Diabetologia; 1994 Jun; 37(6):604-9. PubMed ID: 7926346
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus.
Cook J; Daneman D; Spino M; Sochett E; Perlman K; Balfe JW
J Pediatr; 1990 Jul; 117(1 Pt 1):39-45. PubMed ID: 2196359
[TBL] [Abstract][Full Text] [Related]
8. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
[TBL] [Abstract][Full Text] [Related]
9. [Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy].
Komers R; Malý J; Simková R
Cas Lek Cesk; 1993 Jun; 132(12):359-64. PubMed ID: 8343943
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of captopril on glomerular hyperfiltration in normoalbuminuric normotensive insulin-dependent diabetic patients.
de Azevedo MJ; Ramos OL; Gross JL
Horm Metab Res; 1997 Oct; 29(10):516-9. PubMed ID: 9405980
[TBL] [Abstract][Full Text] [Related]
11. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients.
Wiegmann TB; Herron KG; Chonko AM; MacDougall ML; Moore WV
Diabetes; 1992 Jan; 41(1):62-7. PubMed ID: 1727741
[TBL] [Abstract][Full Text] [Related]
13. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
Parving HH; Hommel E; Damkjaer Nielsen M; Giese J
BMJ; 1989 Aug; 299(6698):533-6. PubMed ID: 2507061
[TBL] [Abstract][Full Text] [Related]
14. [The recovery of the kidney filtration functional reserve in diabetes mellitus patients on captopril treatment].
Shestakova MV; Mukhin NA; Dedov II; Titov VN; Pomerantseva NV; Okunev DIu; Lipitskaia IIa
Ter Arkh; 1991; 63(6):50-5. PubMed ID: 1948747
[TBL] [Abstract][Full Text] [Related]
15. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
Abu-Romeh SH; Nawaz MK; Ali JH; Al-Suhaili AR; Abu-Jayyab AK
Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
[TBL] [Abstract][Full Text] [Related]
16. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients.
Pedersen MM; Schmitz A; Pedersen EB; Danielsen H; Christiansen JS
Diabet Med; 1988 Sep; 5(6):562-9. PubMed ID: 2850132
[TBL] [Abstract][Full Text] [Related]
17. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
Ahmad J; Siddiqui MA; Ahmad H
Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
[TBL] [Abstract][Full Text] [Related]
18. Glomerular dysfunction in diabetic nephropathy.
Zucchelli P; Zuccalà A; Sturani A
Postgrad Med J; 1988; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295
[TBL] [Abstract][Full Text] [Related]
19. Renal haemodynamics during short-term angiotensin converting enzyme inhibition in normotensive normoalbuminuric insulin dependent diabetics.
Vora JP; Hendre TJ; Atiea J; Owens DR
Diabetes Res; 1989 May; 11(1):9-12. PubMed ID: 2695280
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
Mimran A; Insua A; Ribstein J; Monnier L; Bringer J; Mirouze J
J Hypertens; 1988 Nov; 6(11):919-23. PubMed ID: 3069935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
